From: Use of palliative radiotherapy in brain and bone metastases (VARA II study)
H | 1 × 800cGy | 5 × 400 cGy | 10×300cGy | Others | Total |
---|---|---|---|---|---|
1 | 8 | 5 | 13 | ||
61.5% | 38.5% | ||||
2 | 2 | 14 | 1 | 17 | |
11.8% | 82.3% | 5.9% | |||
3 | 12 | 8 | 45 | 9 | 74 |
16.2% | 10.8% | 60.8% | 12.2% | ||
4 | 3 | 12 | 63 | 16 | 94 |
3.2% | 12.8% | 67% | 17% | ||
5 | 36 | 14 | 2 | 52 | |
69.3% | 26.9% | 3.8% | |||
6 | 2 | 6 | 24 | 4 | 36 |
5.6% | 16.7% | 66.7% | 11% | ||
7 | 57 | 20 | 7 | 6 | 90 |
63.3% | 22.2% | 7.8% | 6.7% | ||
8 | 1 | 5 | 1 | 20 | 27 |
3.7% | 18.5% | 3.7% | 74.1% | ||
9 | 16 | 36 | 8 | 54 | 114 |
14% | 31.6% | 7% | 47.4% | ||
10 | 9 | 31 | 20 | 4 | 64 |
14.1% | 48.4% | 31.3% | 6.3% | ||
11 | 44 | 46 | 26 | 10 | 126 |
34.9% | 36.6% | 20.6% | 7.9% | ||
12 | 4 | 8 | 25 | 37 | |
10.8% | 21.6% | 67.6% | |||
T | 184 | 196 | 240 | 124 | 744 |
24.7% | 26.3% | 32.3% | 16.7% |